Get started
Author

Rupanshi Grover

Observed name: R Grover
ORCID: 0000-0003-4235-7545
Observed ORCID: 0000-0003-4235-7545
OpenAlex ID: A5003794199
Recent updates on development of protein-tyrosine phosphatase 1B inhibitors for treatment of diabetes, obesity and related disorders
2022 · Sukhbir Singh, Ajmer Singh Grewal, et al. · Bioorganic Chemistry · 74
A Comprehensive Review on Therapeutic Applications of Ferulic Acid and its Novel Analogues: A Brief Literature
2021 · Ritchu Babbar, Sonia Dhiman, et al. · Mini-Reviews in Medicinal Chemistry · 40
Results of the FREEDOM–C Study: A Pivotal Study of Oral Treprostinil Used Adjunctively with an ERA and/or PDE5-Inhibitor for the Treatment of PAH.
2009 · VF Tapson, F Torres, et al. · American Journal of Respiratory and Critical Care Medicine · 10
Role of Medicinal Plants in the Management of Inflammatory Disorders: An Overview
2023 · Ajmer Singh Grewal, Madhukar Garg, et al. · Recent Advances in Inflammation & Allergy Drug Discovery · 7
Rwd317 the Burden of Japanese Encephalitis in the Asia-pacific: Insights From Real-world Data
2025 · Puneet Kaushik, M. Pharmacy, et al. · Value in Health Regional Issues
PDF
SA61 Obesity Through a Social Lens: A Systematic Review to Deep Dive Into Determinants Affecting Adults in the United States
2025 · Puneet Kaushik, Soumya Nanda, et al. · Value in Health
Works count: 6
Citation count: 131
H-index: 4
I10-index: 3
Year
Topic
Type